<DOC>
	<DOCNO>NCT00567099</DOCNO>
	<brief_summary>The purpose study use magnetoencephalography MEG ( machine measure magnetic activity brain ) electroencephalography EEG ( technique measure electrical activity brain ) study sound processed individual schizophrenia prior initiation aripiprazole treatment three month take antipsychotic medication aripiprazole .</brief_summary>
	<brief_title>Remediation Schizophrenia Sensory Gating Deficit With Aripiprazole</brief_title>
	<detailed_description>Problems attention perception core feature schizophrenia hypothesize result defect filter gate sensory input . Examination require neuroimaging technique high temporal resolution . High-density EEG MEG combination structural magnetic resonance imaging ( sMRI ) use map sensory gating . In number recent study patient treat novel antipsychotic show P50 gate ratio resemble normal control rather schizophrenia subject treatment conventional antipsychotic . To date , literature effect aripiprzole sensory gating . Subjects meet inclusion criterion receive clinical interview , MRI , MEG , neuropsychological test start treatment aripiprazole 3 month later determine patient schizophrenia treat aripiprazole demonstrate sensory gate ratio similar normal control , indicate deficit sensory gating</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Patient Population Diagnosis Schizophrenia determine Structured Clinical Interview DSMIV comorbid diagnosis PTSD continuous treatment conventional antipsychotic , risperidone olanzapine least 3 month absence psychiatric hospitalization least 3 month history drug dependency lifetime history alcohol substance abuse 6 month prior entry study history head injury loss consciousness 5 minute history seizure disorder mood stabilize agent 1865 able sign inform consent Normal Controls Matched age gender patient population No history psychiatric dysfunction alcohol substance dependence lifetime determine SCID No history alcohol substance abuse previous 6 month No family history psychotic disorder first degree relative assess FHRDC diagnostic interview No history head injury loss consciousness 5 minute No history seizure disorder Between 1865 Able sign inform consent Subjects exclude participate study : Require treatment mood stabilizer Have inpatient hospitalization past 3 months\ Have history neurological disorder Have axis I diagnosis besides schizophrenia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Psychiatry</keyword>
	<keyword>Antipsychotic</keyword>
	<keyword>Psychopharmacology</keyword>
	<keyword>Clinical Trial</keyword>
	<keyword>Open Label</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Sensory Gating</keyword>
	<keyword>Attention</keyword>
	<keyword>Memory</keyword>
</DOC>